{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Otorhinolaryngologic+Disease&page=12", "query": { "condition": "Otorhinolaryngologic Disease", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 2312, "total_pages": 232, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Otorhinolaryngologic+Disease&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Otorhinolaryngologic+Disease&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T19:29:53.921Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02728505", "title": "SinuSurf vs. Saline Solution in Normal Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rhinosinusitis" ], "interventions": [ { "name": "SinuSurf irrigation twice daily", "type": "DRUG" }, { "name": "NeilMed Sinus rinse irrigation twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2016-04-12", "completion_date": "2017-01-20", "has_results": false, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02728505" }, { "nct_id": "NCT05789316", "title": "Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Head and Neck Cancer Survivors", "Cancer of the Head and Neck Surviors" ], "interventions": [ { "name": "Ototoxicity Screening Protocol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2023-06-06", "completion_date": "2025-11-21", "has_results": false, "last_update_posted_date": "2026-01-12", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05789316" }, { "nct_id": "NCT02734849", "title": "Study to Evaluate Multiple Doses in Patients With Nasal Polyposis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nasal Polyposis" ], "interventions": [ { "name": "AK001 low dose", "type": "DRUG" }, { "name": "AK001 high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allakos Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2016-04", "completion_date": "2018-01", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 5, "location_summary": "Chicago, Illinois • Boston, Massachusetts • Pittsburgh, Pennsylvania + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734849" }, { "nct_id": "NCT03049358", "title": "Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stage 0 Nasopharyngeal Carcinoma", "Stage 0 Paranasal Sinus Cancer", "Stage I Nasopharyngeal Carcinoma", "Stage I Paranasal Sinus Cancer", "Stage II Nasopharyngeal Carcinoma", "Stage II Paranasal Sinus Cancer", "Stage IIA Nasopharyngeal Carcinoma", "Stage IIB Nasopharyngeal Carcinoma", "Stage III Nasopharyngeal Carcinoma", "Stage III Paranasal Sinus Cancer", "Stage IV Nasopharyngeal Carcinoma", "Stage IV Paranasal Sinus Cancer", "Stage IVA Nasopharyngeal Carcinoma", "Stage IVA Paranasal Sinus Cancer", "Stage IVB Nasopharyngeal Carcinoma", "Stage IVB Paranasal Sinus Cancer", "Stage IVC Nasopharyngeal Carcinoma", "Stage IVC Paranasal Sinus Cancer" ], "interventions": [ { "name": "Physiologic Testing", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Sham Intervention", "type": "PROCEDURE" }, { "name": "Therapeutic Procedure", "type": "PROCEDURE" }, { "name": "rose essential oil", "type": "OTHER" }, { "name": "lemon essential oil", "type": "OTHER" }, { "name": "clove essential oil", "type": "OTHER" }, { "name": "eucalyptus essential oil", "type": "OTHER" }, { "name": "canola oil placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 15, "start_date": "2016-12", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2019-02-05", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03049358" }, { "nct_id": "NCT01544348", "title": "A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Allergic Asthma", "Atopic Dermatitis", "Allergic Rhinitis", "Healthy Volunteers" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Omalizumab", "type": "BIOLOGICAL" }, { "name": "MEDI4212 5 mg Subcutaneous", "type": "BIOLOGICAL" }, { "name": "MEDI4212 15 mg Subcutaneous", "type": "BIOLOGICAL" }, { "name": "MEDI4212 60 mg Subcutaneous", "type": "BIOLOGICAL" }, { "name": "MEDI4212 150 mg Subcutaneous", "type": "BIOLOGICAL" }, { "name": "MEDI4212 300 mg Subcutaneous", "type": "BIOLOGICAL" }, { "name": "MEDI4212 300 mg Intravenous", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 295, "start_date": "2012-01", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-12-30", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 7, "location_summary": "Cypress, California • Glendale, California • Denver, Colorado + 4 more", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01544348" }, { "nct_id": "NCT00310115", "title": "Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bladder Cancer", "Cervical Cancer", "Esophageal Cancer", "Gastric Cancer", "Head and Neck Cancer", "Kidney Cancer", "Leukemia", "Liver Cancer", "Lung Cancer", "Pancreatic Cancer", "Tobacco Use Disorder" ], "interventions": [ { "name": "Smoking Prevention Usual Care", "type": "BEHAVIORAL" }, { "name": "Counseling Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 469, "start_date": "2002-04", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00310115" }, { "nct_id": "NCT05700838", "title": "Refining Cough Skill Training in Parkinson's Disease and Dysphagia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson Disease", "Dysphagia" ], "interventions": [ { "name": "Cough Skill Training - with Variable Practice", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Teachers College, Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "40 Years to 90 Years" }, "enrollment_count": 23, "start_date": "2022-09-21", "completion_date": "2023-06-28", "has_results": false, "last_update_posted_date": "2024-04-11", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05700838" }, { "nct_id": "NCT04110249", "title": "Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Head and Neck Carcinoma", "Head and Neck Lymph Node", "Head and Neck Squamous Cell Carcinoma", "Laryngeal Neoplasm", "Radiation Therapy Recipient" ], "interventions": [ { "name": "Photoacoustic Imaging", "type": "PROCEDURE" }, { "name": "Transcutaneous Acupoint Electrical Stimulation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2019-09-06", "completion_date": "2022-12-29", "has_results": false, "last_update_posted_date": "2023-04-10", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04110249" }, { "nct_id": "NCT01861704", "title": "Post-market Study to Capture Information Regarding Performance of Lyric2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hearing Loss" ], "interventions": [ { "name": "Lyric", "type": "DEVICE" }, { "name": "Lyric2", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Phonak AG, Switzerland", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 177, "start_date": "2011-04", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2014-05-19", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 1, "location_summary": "Newark, California", "locations": [ { "city": "Newark", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01861704" }, { "nct_id": "NCT00000752", "title": "Preventing Frequent Sinus Infections in HIV-Infected Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "Sinusitis" ], "interventions": [ { "name": "Pseudoephedrine hydrochloride", "type": "DRUG" }, { "name": "Guaifenesin", "type": "DRUG" }, { "name": "Cefuroxime axetil", "type": "DRUG" }, { "name": "Beclomethasone dipropionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": null, "completion_date": "1993-02", "has_results": false, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-14T19:29:53.921Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • The Bronx, New York + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "The Bronx", "state": "New York" }, { "city": "The Bronx", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000752" } ] }